Bioregenx (BRGX) Net Income towards Common Stockholders (2022 - 2026)
Bioregenx (BRGX) posted quarterly Net Income towards Common Stockholders of -$126850.0 for Q1 2026, up 52.46% year-over-year from -$83199.6 in Q1 2025, and up 87.54% quarter-over-quarter from -$1.0 million in Q4 2025.
Bioregenx (BRGX) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
Bioregenx's Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at -$126850.0 for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 52.46% year-over-year to -$126850.0; the TTM figure through Mar 2026 stood at -$1.4 million (up 94.33% YoY), while the FY2025 annual figure was -$3.7 million, up 85.82% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$126850.0, up from -$1.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$2191.0 in Q3 2022, with the low at -$18.6 million in Q4 2024.
- The 5-year median for Net Income towards Common Stockholders is -$178345.0 (2025), against an average of -$1.6 million.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders plunged 79554.84% in 2024, then surged 96.87% in 2025.
- Bioregenx's Net Income towards Common Stockholders stood at -$5535.0 in 2022, then sank by 12907.52% to -$719966.0 in 2023, then sank by 2484.09% to -$18.6 million in 2024, then soared by 94.53% to -$1.0 million in 2025, then jumped by 87.54% to -$126850.0 in 2026.
- Business Quant data shows BRGX's Net Income towards Common Stockholders at -$126850.0 in Q1 2026, -$1.0 million in Q4 2025, and -$80565.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 84.30 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 69.42 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -17.93 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 43.10 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 40.87 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 24.32 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -15.74 Mn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | -126,850.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,850.00 |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -80,565.00 |
| Jun 30, 2025 | -178,345.00 |
| Mar 31, 2025 | -266,854.00 |
| Dec 31, 2024 | -18.60 Mn |
| Sep 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -704,806.00 |
| Dec 31, 2023 | -719,966.00 |
| Sep 30, 2023 | -3,691.00 |
| Jun 30, 2023 | -4,128.00 |
| Mar 31, 2023 | -229,838.00 |
| Dec 31, 2022 | -5,535.00 |
| Sep 30, 2022 | -2,191.00 |
| Jun 30, 2022 | -33,263.00 |
| Mar 31, 2022 | -37,319.00 |